Abstract: The invention relates to a method for detecting and/or identifying magnetic supraparticles using magnet particle spectroscopy (MPS) or magnet particle imaging (MPI), wherein magnetic supraparticles are provided, each of which contains a plurality of magnetic nanoparticles and which have a specific composition and/or structure. The magnetic supraparticles are exposed to at least one magnetic field, whereby at least one voltage and/or a voltage curve is induced based on the magnetic moment of the magnetic supraparticles. The at least one voltage and/or the voltage curve is detected as at least one measurement signal, and at least one spectrum is generated from the at least one measurement signal, said spectrum containing harmonics, each of which has an amplitude and a phase. The magnetic supraparticles are (uniquely) detected and/or identified using the at least one generated spectrum.

Abstract: The present invention relates to an electrode catheter for defibrillation, mapping or ablation of cardiac tissue. Said catheter comprises a terminal (40) on the proximal end of the electrode catheter and one or more sensing and/or treatment electrodes (14, 16) that are situated on or in the vicinity of the distal end of the electrode catheter, in addition to at least one electric conductor (44, 62), which is used to electrically connect a respective sensing or treatment electrode to the terminal. The electric conductor (44, 62) is composed of carbon and the electrode catheter is configured to be suitable for us as part of magnetic resonance tomography and for connection to electrophysiotherapy equipment. Said catheter comprises at least one defibrillation electrode, or at least one sensing electrode (14, 16) for the recording and evaluation of cardiac tissue potentials, or at least one treatment electrode (14) for delivering high-frequency currents for ablation purposes.

Abstract: The present invention relates to an electrode catheter for defibrillation, mapping or ablation of cardiac tissue. Said catheter comprises a terminal (40) on the proximal end of the electrode catheter and one or more sensing and/or treatment electrodes (14, 16) that are situated on or in the vicinity of the distal end of the electrode catheter, in addition to at least one electric conductor (44, 62), which is used to electrically connect a respective sensing or treatment electrode to the terminal. The electric conductor (44, 62) is composed of carbon and the electrode catheter is configured to be suitable for us as part of magnetic resonance tomography and for connection to electrophysiotherapy equipment. Said catheter comprises at least one defibrillation electrode, or at least one sensing electrode (14, 16) for the recording and evaluation of cardiac tissue potentials, or at least one treatment electrode (14) for delivering high-frequency currents for ablation purposes.